<DOC>
	<DOCNO>NCT01313364</DOCNO>
	<brief_summary>This single-arm , single-center study healthy volunteer . This study design evaluate safety IM injection use single-use autoinjector 25G × 1 '' needle . The purpose study evaluate study treatment ; therefore , injection perform Avonex placebo ; active IFNβ-1a administered .</brief_summary>
	<brief_title>A Safety Study Healthy Volunteers Single-Use Autoinjector Containing Placebo BG9418 Interferon Beta-1a With 25-Gauge × 1-Inch Needle</brief_title>
	<detailed_description>This single-arm , single-center study healthy volunteer . The study design evaluate safe use single-use autoinjector 25G × 1 '' needle subject vary body mass index ( BMIs ) . Because safety study injector , injection contain Avonex excipients ; active IFNβ-1a administer . During study , subject self-administer 4 IM injection use single-use autoinjector . Subjects self-administer first 2 injection ( 1 thigh ) repeat process approximately 60 90 minute later . A Trainer/Observer prepare autoinjector injection , monitor injection , ass subject AEs injection process time discharge unit . The Trainer/Observer also visually inspect needle pre- post-injection record finding . The Investigator designee ( physician nurse ) ass injection sit erythema , induration , tenderness , warmth .</detailed_description>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Healthy male female , age 18 65 year , inclusive , time informed consent Able understand comply protocol Must English French speak At investigator 's opinion , must willing able perform selfinjections right leave thigh singleuse autoinjector Abnormal screen blood test determine clinically significant Investigator Treatment systemic anticoagulant within previous 30 day Treatment aspirin within previous 7 day nonsteroidal antiinflammatory drug ( NSAIDs ) within previous 3 day History severe allergic anaphylactic reaction History clinically significant cardiac , endocrinologic , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , pyschiatric , renal , and/or major disease include bleed disorder Current enrollment investigational study Female subject currently pregnant History alcohol substance abuse positive drug screen test day 1 Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>